Merck KGaA (OTCMKTS:MKKGY) Shares Shorted: Short Interest Down 68.5% in October

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 46,022 shares, a drop of 68.5% from the October 15th total of 146,247 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 104,760 shares, the days-to-cover ratio is presently 0.4 days.

Merck KGaA Stock Up 1.5%

OTCMKTS MKKGY traded up $0.50 during trading hours on Friday, hitting $33.12. The company had a trading volume of 20,663 shares, compared to its average volume of 94,101. The firm’s 50 day moving average is $31.72 and its 200 day moving average is $30.08. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.69 and a quick ratio of 1.09. Merck KGaA has a fifty-two week low of $23.73 and a fifty-two week high of $34.19. The company has a market capitalization of $21.40 billion, a price-to-earnings ratio of 17.07, a P/E/G ratio of 2.93 and a beta of 0.92.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on MKKGY shares. Zacks Research upgraded Merck KGaA from a “strong sell” rating to a “hold” rating in a report on Tuesday. UBS Group lowered shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Six investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Read Our Latest Analysis on Merck KGaA

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility.

See Also

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.